MESA LABORATORIES INC /CO/
For the period ended Mar 31, 2026. Filed Jun 3, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jun 3, 2026
MLAB$136.91+7.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
ConsolidatedStatements of Cash Flows
(In thousands)
| Year Ended March 31, | |||
|---|---|---|---|
| 2026 | 2025 | 2024 | |
| Cash flows from operating activities: | |||
| Net income (loss) | $6,712 | $(1,974) | $(254,246) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||
| Depreciation of property, plant and equipment | 5,254 | 5,382 | 4,233 |
| Amortization of acquisition-related intangibles | 18,017 | 19,145 | 27,341 |
| Stock-based compensation expense | 17,868 | 13,142 | 11,936 |
| Non-cash interest expense and debt issuance cost amortization | 682 | 990 | 926 |
| Gain on extinguishment of convertible senior notes | - | (2,887) | - |
| Amortization of step-up in inventory basis | - | 1,232 | 1,229 |
| Deferred taxes | (1,292) | (72) | (28,421) |
| Impairment loss on goodwill and finite-lived intangible assets | - | - | 274,533 |
| Other | 577 | 4,946 | 629 |
| Cash from changes in operating assets and liabilities: | |||
| Accounts receivable | (3,206) | (2,925) | 4,940 |
| Inventories | (4,434) | 1,153 | 2,563 |
| Prepaid expenses and other assets | 608 | 498 | 211 |
| Accounts payable | (1,197) | (388) | (97) |
| Accrued liabilities and taxes payable | 3,497 | 9,504 | (1,236) |
| Unearned revenues | (255) | (938) | (408) |
| Net cash provided by operating activities | 42,831 | 46,808 | 44,133 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (3,250) | (4,249) | (2,567) |
| Acquisition of customer lists | - | (250) | - |
| Acquisition of businesses, net of cash acquired and holdback liabilities | - | - | (78,739) |
| Net cash (used in) investing activities | (3,250) | (4,499) | (81,306) |
| Cash flows from financing activities: | |||
| Proceeds from debt borrowings | 107,500 | 73,465 | 71,000 |
| Repurchase of convertible note debt | (97,500) | (71,560) | - |
| Other debt principal repayments | (36,749) | (44,251) | (33,500) |
| GKE acquisition holdback payment | (9,555) | - | - |
| Dividends paid | (3,523) | (3,468) | (3,447) |
| Payment of tax withholding obligation on vesting of restricted stock | (1,061) | (887) | (728) |
| Proceeds from the exercise of stock options | - | 2,644 | 358 |
| Other financing, net | (966) | (452) | (847) |
| Net cash (used in) provided by financing activities | (41,854) | (44,509) | 32,836 |
| Effect of exchange rate changes on cash and cash equivalents | 1,880 | 1,307 | (359) |
| Net (decrease) in cash and cash equivalents | (393) | (893) | (4,696) |
| Cash and cash equivalents at beginning of period | 27,321 | 28,214 | 32,910 |
| Cash and cash equivalents at end of period | $26,928 | $27,321 | $28,214 |
| Cash paid for: | |||
|---|---|---|---|
| Income taxes | $1,870 | $5,731 | $4,591 |
| Interest | $10,017 | $11,077 | $4,648 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.